Mitochondrial Metabolism: A New Dimension of Personalized Oncology
Cancers · 11.08.2023 · 15 (16) · 4058
DOI: 10.3390/cancers15164058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.08.2023. Verfasst von Babak Behnam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulatory Affairs, Amarex Clinical Research, NSF International, Germantown, MD 20874, USA. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Energy is needed by cancer cells to stay alive and communicate with their surroundings. The primary organelles for cellular metabolism and energy synthesis are mitochondria. Researchers recently proved that cancer cells can steal immune cells’ mitochondria using nanoscale tubes. This finding demonstrates the dependence of cancer cells on normal cells for their living and function. It also denotes the importance of mitochondria in cancer cells’ biology. Emerging evidence has demonstrated how mitochondria are essential for cancer cells to survive in the harsh tumor microenvironments, evade the immune system, obtain more aggressive features, and resist treatments. For instance, functional mitochondria can improve cancer resistance against radiotherapy by scavenging the released reactive oxygen species. Therefore, targeting mitochondria can potentially enhance oncological outcomes, according to this notion. The tumors’ responses to anticancer treatments vary, ranging from a complete response to even cancer progression during treatment. Therefore, personalized cancer treatment is of crucial importance. So far, personalized cancer treatment has been based on genomic analysis. Evidence shows that tumors with high mitochondrial content are more resistant to treatment. This paper illustrates how mitochondrial metabolism can participate in cancer resistance to chemotherapy, immunotherapy, and radiotherapy. Pretreatment evaluation of mitochondrial metabolism can provide additional information to genomic analysis and can help to improve personalized oncological treatments. This article outlines the importance of mitochondrial metabolism in cancer biology and personalized treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Regulatory Affairs, Amarex Clinical Research, NSF International, Germantown, MD 20874, USA.
- ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran 1445613131, Iran.
- Department of Radiation Oncology, Iran University of Medical Sciences, Tehran 1445613131, Iran.
ORCID-Profile: Babak Behnam, Farzad Taghizadeh-Hesary
Zitieren
APA
Behnam, B., & Taghizadeh-Hesary, F. (2023). Mitochondrial Metabolism: A New Dimension of Personalized Oncology. Cancers, 15(16), 4058. https://doi.org/10.3390/cancers15164058
Vancouver
Behnam B, Taghizadeh-Hesary F. Mitochondrial Metabolism: A New Dimension of Personalized Oncology. Cancers. 2023;15(16):4058. doi:10.3390/cancers15164058
BibTeX
@article{Behnam2023,
author = {Behnam, Babak and Taghizadeh-Hesary, Farzad},
title = {Mitochondrial Metabolism: A New Dimension of Personalized Oncology},
journal = {Cancers},
year = {2023},
volume = {15},
number = {16},
pages = {4058},
doi = {10.3390/cancers15164058}
}
EUVIMED